If President Trump succeeded in his aim of cutting prescription drug prices by 50% “almost immediately”, it could subtract more than 1%-point from headline PCE inflation. There is little indication of how the administration will achieve that aim, however, and the more immediate risk to drug prices is that the administration follows through on its threat to impose tariffs on pharmaceutical imports.
Subscriber content
Read this in full, free
Start a free trial and use one of your 10 free starter credits to unlock this piece.